COLLAGENEX PHARMACEUTICALS INC 4
4 · COLLAGENEX PHARMACEUTICALS INC · Filed Jun 14, 2007
Insider Transaction Report
Form 4
PFEIFFER DAVID F
Sr. VP, Sales and Marketing
Transactions
- Sale
Common Stock
2007-06-11$12.05/sh−900$10,845→ 16,400 total - Sale
Common Stock
2007-06-11$12.06/sh−1,000$12,060→ 17,300 total - Sale
Common Stock
2007-06-11$12.00/sh−800$9,600→ 20,700 total - Sale
Common Stock
2007-06-11$12.08/sh−3,028$36,578→ 12,900 total - Exercise/Conversion
Common Stock
2007-06-11$10.63/sh+10,000$106,250→ 21,500 total - Sale
Common Stock
2007-06-11$11.99/sh−1,200$14,388→ 19,500 total - Sale
Common Stock
2007-06-11$12.02/sh−500$6,010→ 11,500 total - Sale
Common Stock
2007-06-11$12.09/sh−472$5,706→ 15,928 total - Sale
Common Stock
2007-06-11$12.04/sh−200$2,408→ 12,000 total - Sale
Common Stock
2007-06-11$12.07/sh−700$8,449→ 12,200 total - Exercise/Conversion
Option to purchase common stock
2007-06-11−10,000→ 359,400 totalExercise: $10.63Exp: 2007-07-22→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2006.
- [F2]Represents options granted by the Issuer pursuant to its 1996 Stock Option Plan on July 23, 1997. Such options vest as follows: 2,000 shares subject to such options vested on July 23, 1998, 2,000 shares subject to such options vested on July 23, 1999, 2,000 shares subject to such options vested on July 23, 2000, 2,000 shares subject to such options vested on July 23, 2001 and 2,000 shares subject to such options vested on July 23, 2002.
- [F3]Includes multiple option grants with different prices and vesting dates.